Cargando…
A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas
SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488775/ https://www.ncbi.nlm.nih.gov/pubmed/36126083 http://dx.doi.org/10.1371/journal.pone.0274823 |
_version_ | 1784792734084628480 |
---|---|
author | Dai, Lei Mugaanyi, Joseph Zhang, Tongyue Tong, Jingshu Cai, Xingchen Lu, Caide Lu, Changjiang |
author_facet | Dai, Lei Mugaanyi, Joseph Zhang, Tongyue Tong, Jingshu Cai, Xingchen Lu, Caide Lu, Changjiang |
author_sort | Dai, Lei |
collection | PubMed |
description | SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The expression level of SMARCA1 was positively correlated with cancer-associated fibroblasts infiltration in a number of tumors, such as colon adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma. It was also associated with CD8+ T-cell infiltration in head and neck squamous cell carcinoma and lung adenocarcinoma. Furthermore, SMARCA1 is involved in chromatin remodeling and protein processing-associated mechanisms. Our study presents an initial assessment and illustration of the carcinogenic role of SMARCA1 in different carcinomas. |
format | Online Article Text |
id | pubmed-9488775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-94887752022-09-21 A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas Dai, Lei Mugaanyi, Joseph Zhang, Tongyue Tong, Jingshu Cai, Xingchen Lu, Caide Lu, Changjiang PLoS One Research Article SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The expression level of SMARCA1 was positively correlated with cancer-associated fibroblasts infiltration in a number of tumors, such as colon adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma. It was also associated with CD8+ T-cell infiltration in head and neck squamous cell carcinoma and lung adenocarcinoma. Furthermore, SMARCA1 is involved in chromatin remodeling and protein processing-associated mechanisms. Our study presents an initial assessment and illustration of the carcinogenic role of SMARCA1 in different carcinomas. Public Library of Science 2022-09-20 /pmc/articles/PMC9488775/ /pubmed/36126083 http://dx.doi.org/10.1371/journal.pone.0274823 Text en © 2022 Dai et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Dai, Lei Mugaanyi, Joseph Zhang, Tongyue Tong, Jingshu Cai, Xingchen Lu, Caide Lu, Changjiang A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas |
title | A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas |
title_full | A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas |
title_fullStr | A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas |
title_full_unstemmed | A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas |
title_short | A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas |
title_sort | pan-cancer bioinformatic analysis of the carcinogenic role of smarca1 in human carcinomas |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488775/ https://www.ncbi.nlm.nih.gov/pubmed/36126083 http://dx.doi.org/10.1371/journal.pone.0274823 |
work_keys_str_mv | AT dailei apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT mugaanyijoseph apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT zhangtongyue apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT tongjingshu apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT caixingchen apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT lucaide apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT luchangjiang apancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT dailei pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT mugaanyijoseph pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT zhangtongyue pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT tongjingshu pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT caixingchen pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT lucaide pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas AT luchangjiang pancancerbioinformaticanalysisofthecarcinogenicroleofsmarca1inhumancarcinomas |